KRT8 and adenocarcinoma: Then, mQIF was employed to validate the expression pattern of FMNL1 using co-staining of FMNL1, CD45 (a biomarker for most immune cells), and CK8 (a biomarker for glandular epithelium and adenocarcinoma cell).